Cord Blood is the blood collected from placenta, it is left over in the placenta and in the umbilical cord after the birth of the baby. In the past, cord blood is disposed along with the placenta as clinical waste. Thanks to the advancement of medical science and biotechnology, the medical value of cord blood is unveiled.
Cord blood is rich of Hematopoietic Stem Cells (HSCs) which can differentiate into blood and immune system cells and have significant medical value. Up to 113 diseases such as cancers, blood-related, immunity and metabolic diseases can be treated by cord blood5,6.
In 1988, a 5-year-old boy suffering from Fanconi's Anemia successfully received transplantation of his younger sister's cord blood, which was the first clinical application of cord blood and aroused worldwide enthusiasm about cord blood storage. At present, up to 113 treatable diseases including cancers, blood-related, immunity and metabolic disorders can be treated by cord blood5,6.
Cord Blood is collected after the infant leaves the mother's body and the umbilical cord is cut, so the process of cord blood collection is absolutely safe and painless for both mother and infant. The quantity of cord blood depends on the size of the placenta and the thickness of the umbilical cord, it about 60ml on average for Asian. Every single drop of cord blood is rich in stem cells, so doctors will endeavor to collect as much cord blood as possible.
Thanks to the advancement of biotechnology, At present, up to 113 clinical diseases can be treated by cord blood and the number of FDA regulated clinical trials related to cord blood medical applications is constantly on the rise each year5,6, including neurological diseases, autoimmune system damage, cardiovascular disease are the main three categories of it. It is believed the number of treatable diseases will keep growing in the future.